Monrad
Vallensbæk

Sundhedsfagligt planlagt tilsyn med fokus på demens og antipsykotisk medicin i Sygeplejen

26/1394 -

Prompt resultater

Relevans v1

Relevans

Nej

Bilag

First-agenda Sagsfremstilling

Beslutningstema

Styrelsen for Patientsikkerhed har udført sundhedsfagligt, planlagt tilsyn med fokus på borgere med demens, som bliver behandlet med antipsykotisk medicin, i Sygeplejen den 26. februar 2026.

Indstilling

Sagen bliver behandlet i Social-, Sundheds- og Ældreudvalget.

 

Center for Pleje og Omsorg indstiller,

 

  • at orienteringen om det sundhedsfaglige planlagte tilsyn i Sygeplejen den 26. februar 2026 bliver taget til efterretning

 

  • at sagen sammen med tilsynsrapporten bliver sendt til orientering i Vallensbæk Seniorråd

Sagsfremstilling

Styrelsen for Patientsikkerhed udfører sundhedsfaglige tilsyn med hjemmepleje- og sygeplejeenheder. Tilsynet var planlagt på baggrund af en stikprøve af tilfældigt udvalgte steder i hele landet. I dette tilsyn var Sygeplejen udvalgt med fokus på borgere med demens, som er i behandling med antipsykotisk medicin.

 

Den endelige tilsynsrapport blev sendt til forvaltningen den 6. marts 2026.

 

Overordnet konklusion

Tilsynet kategoriserer behandlingsstederne i følgende kategorier:

 

  • Ingen problemer af betydning for patientsikkerheden
  • Mindre problemer af betydning for patientsikkerheden
  • Større problemer af betydning for patientsikkerheden
  • Kritiske problemer af betydning for patientsikkerheden

 

Styrelsen for Patientsikkerhed vurderede, at Sygeplejen fremstod sundhedsfagligt velorganiseret med gode arbejdsgange og en høj grad af systematik. Styrelsen kategoriserede ud fra tilsynet Sygeplejen i kategorien:

 

  • Ingen problemer af betydning for patientsikkerheden

 

Tilsynets fund

Styrelsen for Patientsikkerhed har i tilsynet vurderet Sygeplejen inden for følgende overskrifter:

 

  • Organisering
  • Journalføring
  • Medicinhåndtering
  • Øvrige fund

 

Tilsynet er gennemført med fokus på 13 målepunkter indenfor de fire overskrifter. Der blev ikke fundet fejl eller mangler og alle målepunkter er dermed opfyldt.

 

Styrelsen stiller ingen krav eller henstillinger på baggrund af tilsynet.

Økonomi- og personalemæssige konsekvenser

Ingen bemærkninger.

Sammenhæng til udviklingsstrategien

Sagen har relation til delvision 3, Livskvalitet i et godt og sundt liv i kommunens udviklingsstrategi.

Sammenhæng til FN's verdensmål

Kommunikation

Rapporten er offentliggjort på Styrelsen for Patientsikkerheds hjemmeside, på Vallensbæk Kommunes hjemmeside og vil fremover fremgå af Plejeoverblikket.

Retsgrundlag

Sundhedsloven §213.

 

BILAG:

1 - 1846058 Åben Tilsynsrapport (8023/26)

Er du enig eller uenig?

22 items
  • Lydfiler null
  • Ressourcer null
  • Felter 1 items
    1. 6 items
      • Navn ""
      • Html "<div><div id='sagsfremstillingContainer'> <h3>Beslutningstema</h3> <span class='beslutningstema'><meta http-equiv="Content-Type" content="text/html; charset=utf-8"><meta http-equiv="Content-Style-Type" content="text/css"><meta name="generator" content="Aspose.Words for .NET 22.1.0"><title></title><div><p style="margin-top:0pt; margin-bottom:0pt;"><span>Styrelsen for Patientsikkerhed har udført sundhedsfagligt, planlagt tilsyn med fokus på borgere med demens, som bliver behandlet med antipsykotisk medicin, i Sygeplejen den 26. februar 2026.</span></p></div></span> <div><h3>Indstilling</h3> <span class='indstilling'><meta http-equiv="Content-Type" content="text/html; charset=utf-8"><meta http-equiv="Content-Style-Type" content="text/css"><meta name="generator" content="Aspose.Words for .NET 22.1.0"><title></title><div><p style="margin-top:0pt; margin-bottom:0pt;"><span>Sagen bliver behandlet i Social-, Sundheds- og Ældreudvalget. </span></p><p style="margin-top:0pt; margin-bottom:0pt;"><span> </span></p><p style="margin-top:0pt; margin-bottom:0pt;"><span>Center for Pleje og Omsorg indstiller,</span></p><p style="margin-top:0pt; margin-bottom:0pt;"><span> </span></p><ul type="disc" style=" padding-left:0pt;"><li style="margin-left:27.6pt; padding-left:8.4pt;"><span>at orienteringen om det sundhedsfaglige planlagte tilsyn i Sygeplejen den 26. februar 2026 bliver taget til efterretning</span></li></ul><p style="margin-top:0pt; margin-left:36pt; margin-bottom:0pt;"><span> </span></p><ul type="disc" style=" padding-left:0pt;"><li style="margin-left:27.6pt; padding-left:8.4pt;"><span>at sagen sammen med tilsynsrapporten bliver sendt til orientering i Vallensbæk Seniorråd</span></li></ul></div></span> </div> <h3>Sagsfremstilling</h3> <span><meta http-equiv="Content-Type" content="text/html; charset=utf-8"><meta http-equiv="Content-Style-Type" content="text/css"><meta name="generator" content="Aspose.Words for .NET 22.1.0"><title></title><div><p style="margin-top:0pt; margin-bottom:0pt;"><span>Styrelsen for Patientsikkerhed udfører sundhedsfaglige tilsyn med hjemmepleje- og sygeplejeenheder. Tilsynet var planlagt på baggrund af en stikprøve af tilfældigt udvalgte steder i hele landet. I dette tilsyn var Sygeplejen udvalgt med fokus på borgere med demens, som er i behandling med antipsykotisk medicin.</span></p><p style="margin-top:0pt; margin-bottom:0pt;"><span> </span></p><p style="margin-top:0pt; margin-bottom:0pt;"><span>Den endelige tilsynsrapport blev sendt til forvaltningen den 6. marts 2026.</span></p><p style="margin-top:0pt; margin-bottom:0pt;"><span> </span></p><p style="margin-top:0pt; margin-bottom:0pt;"><span>Overordnet konklusion</span></p><p style="margin-top:0pt; margin-bottom:0pt;"><span>Tilsynet kategoriserer behandlingsstederne i følgende kategorier:</span></p><p style="margin-top:0pt; margin-bottom:0pt;"><span> </span></p><ul type="disc" style=" padding-left:0pt;"><li style="margin-left:27.6pt; padding-left:8.4pt;"><span>Ingen problemer af betydning for patientsikkerheden</span></li><li style="margin-left:27.6pt; padding-left:8.4pt;"><span>Mindre problemer af betydning for patientsikkerheden</span></li><li style="margin-left:27.6pt; padding-left:8.4pt;"><span>Større problemer af betydning for patientsikkerheden </span></li><li style="margin-left:27.6pt; padding-left:8.4pt;"><span>Kritiske problemer af betydning for patientsikkerheden</span></li></ul><p style="margin-top:0pt; margin-bottom:0pt;"><span> </span></p><p style="margin-top:0pt; margin-bottom:0pt;"><span>Styrelsen for Patientsikkerhed vurderede, at Sygeplejen fremstod sundhedsfagligt velorganiseret med gode arbejdsgange og en høj grad af systematik. Styrelsen kategoriserede ud fra tilsynet Sygeplejen i kategorien:</span></p><p style="margin-top:0pt; margin-bottom:0pt;"><span> </span></p><ul type="disc" style=" padding-left:0pt;"><li style="margin-left:27.6pt; padding-left:8.4pt;"><span>Ingen problemer af betydning for patientsikkerheden</span></li></ul><p style="margin-top:0pt; margin-bottom:0pt;"><span> </span></p><p style="margin-top:0pt; margin-bottom:0pt;"><span>Tilsynets fund</span></p><p style="margin-top:0pt; margin-bottom:0pt;"><span>Styrelsen for Patientsikkerhed har i tilsynet vurderet Sygeplejen inden for følgende overskrifter:</span></p><p style="margin-top:0pt; margin-bottom:0pt;"><span> </span></p><ul type="disc" style=" padding-left:0pt;"><li style="margin-left:27.6pt; padding-left:8.4pt;"><span>Organisering </span></li><li style="margin-left:27.6pt; padding-left:8.4pt;"><span>Journalføring</span></li><li style="margin-left:27.6pt; padding-left:8.4pt;"><span>Medicinhåndtering </span></li><li style="margin-left:27.6pt; padding-left:8.4pt;"><span>Øvrige fund </span></li></ul><p style="margin-top:0pt; margin-bottom:0pt;"><span> </span></p><p style="margin-top:0pt; margin-bottom:0pt;"><span>Tilsynet er gennemført med fokus på 13 målepunkter indenfor de fire overskrifter. Der blev ikke fundet fejl eller mangler og alle målepunkter er dermed opfyldt.</span></p><p style="margin-top:0pt; margin-bottom:0pt;"><span> </span></p><p style="margin-top:0pt; margin-bottom:0pt;"><span>Styrelsen stiller ingen krav eller henstillinger på baggrund af tilsynet.</span></p></div></span> <h3>Økonomi- og personalemæssige konsekvenser</h3> <span class='ukendt'><meta http-equiv="Content-Type" content="text/html; charset=utf-8"><meta http-equiv="Content-Style-Type" content="text/css"><meta name="generator" content="Aspose.Words for .NET 22.1.0"><title></title><div><p style="margin-top:0pt; margin-bottom:0pt;"><span>Ingen bemærkninger.</span></p></div></span> <h3>Sammenhæng til udviklingsstrategien</h3> <span class='ukendt'><meta http-equiv="Content-Type" content="text/html; charset=utf-8"><meta http-equiv="Content-Style-Type" content="text/css"><meta name="generator" content="Aspose.Words for .NET 22.1.0"><title></title><div><p style="margin-top:0pt; margin-bottom:0pt;"><span>Sagen har relation til delvision 3, Livskvalitet i et godt og sundt liv i kommunens udviklingsstrategi.</span></p></div></span> <h3>Sammenhæng til FN's verdensmål</h3> <span class='ukendt'><meta http-equiv="Content-Type" content="text/html; charset=utf-8"><meta http-equiv="Content-Style-Type" content="text/css"><meta name="generator" content="Aspose.Words for .NET 22.1.0"><title></title><div><p style="margin-top:0pt; margin-bottom:0pt;"><img src="data:image/jpeg;base64,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" width="643" height="38" alt=""></p></div></span> <h3>Kommunikation</h3> <span class='ukendt'><meta http-equiv="Content-Type" content="text/html; charset=utf-8"><meta http-equiv="Content-Style-Type" content="text/css"><meta name="generator" content="Aspose.Words for .NET 22.1.0"><title></title><div><p style="margin-top:0pt; margin-bottom:0pt;"><span>Rapporten er offentliggjort på Styrelsen for Patientsikkerheds hjemmeside, på Vallensbæk Kommunes hjemmeside og vil fremover fremgå af Plejeoverblikket.</span></p></div></span> <h3>Retsgrundlag</h3> <span class='ukendt'><meta http-equiv="Content-Type" content="text/html; charset=utf-8"><meta http-equiv="Content-Style-Type" content="text/css"><meta name="generator" content="Aspose.Words for .NET 22.1.0"><title></title><div><p style="margin-top:0pt; margin-bottom:0pt;"><span>Sundhedsloven §213.</span></p><p style="margin-top:0pt; margin-bottom:0pt;"><span> </span></p><p style="margin-top:0pt; margin-bottom:0pt;"><span>BILAG:</span></p><p style="margin-top:0pt; margin-bottom:0pt;"><span>1 - 1846058</span><span> </span><span>Åben</span><span> </span><span>Tilsynsrapport</span><span> </span><span>(8023/26)</span></p></div></span> </div></div>"
      • Tekst null
      • Id "00000000-0000-0000-0000-000000000000"
      • Link "https://dagsordener.vallensbaek.dk/Vis/Pdf/bilag/8adb241c-b948-464b-9e5d-3754c03025ce"
      • DocumentId "8adb241c-b948-464b-9e5d-3754c03025ce"
  • Presentations null
  • ItemDecision null
  • SagsNummer "26/1394"
  • Navn "Sundhedsfagligt planlagt tilsyn med fokus på demens og antipsykotisk medicin i Sygeplejen"
  • Punktnummer "7"
  • Bilag 0 items
    1. Documents null
    2. Id "2fd7301f-2244-4d8c-a9a0-7d27e76a0415"
    3. IntegrationUid "00000000-0000-0000-0000-000000000000"
    4. CorporationUid "00000000-0000-0000-0000-000000000000"
    5. AgendaUid "2cbc5c21-3ac9-48bc-9ea2-93ab83eb3a13"
    6. Number "7"
    7. Sorting 7
    8. IsOpen true
    9. CaseNumber "26/1394"
    10. SourceId "14075"
    11. Caption "Sundhedsfagligt planlagt tilsyn med fokus på demens og antipsykotisk medicin i Sygeplejen"
    12. CasePresentationUid null
    13. ExternalAgendaItemAttendees 0 items